Director, Pathology Services

Agilent Technologies•Los Angeles, CA
•$187,721 - $328,950•Remote

About The Position

Be a part of the future of Precision Medicine! Our mission is to improve the human condition by bringing the power of precision medicine to labs, partners, and patients globally. In the Companion Diagnostics Business (CDx), our team partners very closely with leading biopharma companies to develop, manufacture and commercialize highly regulated medical devices which are critical for physicians to help select therapies for their patients.

Requirements

  • Bachelors of Science degree and/or higher education
  • Prior experience working in a pathology setting and understanding workflow issues
  • 10+ years cancer diagnostic assay experience including IHC
  • Management and companion diagnostic development experience
  • Participate in cross functional team meetings representing Pathology

Responsibilities

  • Manage project assignments for Agilent pathologists and overall workload
  • Oversee the Pathology Services team, including slide shipment coordination and consultant pathologists, schedules, workload and project assignments
  • Develop and manage workflow process for pathology and for contribution to companion diagnostics clinical trials
  • Collaborate with Clinical, R&D, Regulatory and QA to meet companion diagnostic biopharma partner project needs and timelines
  • Oversight of pathologists ICQ tissue samples review, develop scoring algorithms and provide experienced guidance for Agilent companion diagnostic assay development
  • Prepare digital pathology strategy for pathologist assay scoring training and support digital image analysis
  • Collaborate with commercial initiatives for product launches
  • Contribute to and present on future directions of growth opportunities with biopharma partners
  • Oversee the IQC evaluation of tissue samples for Agilent CDx assays
  • PI “Protocol for Reagent Optimization and In Vitro Diagnostic Assay Development” at Agilent R&D lab
  • Ensuring IRB/IEC review of study information for initial and continuing approval of the study

Benefits

  • eligibility for bonus
  • stock
  • benefits
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service